Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease

Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries, Henry N. Ginsberg, Luis Masana, Olivier S. Descamps, Olov Wiklund, Robert A. Hegele, Frederick J. Raal, Joep C. Defesche, Albert Wiegman, Raul D. Santos, Gerald F. Watts, Klaus G. Parhofer, G. Kees Hovingh, Petri T. Kovanen, Catherine Boileau, Maurizio Averna, Jan Borén, Eric BruckertAlberico L. Catapano, Jan Albert Kuivenhoven, Päivi Pajukanta, Kausik Ray, Anton F H Stalenhoef, Erik Stroes, Marja Riitta Taskinen, Anne Tybjærg-Hansen

Research output: Contribution to journalArticlepeer-review

Abstract

Aims The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease (CHD). Methods and results Of the theoretical estimated prevalence of 1/500 for heterozygous FH,

Original languageEnglish
JournalEuropean Heart Journal
Volume34
Issue number45
DOIs
Publication statusPublished - Dec 1 2013

Keywords

  • Atherosclerosis
  • Cardiovascular disease
  • Cholesterol
  • Coronary heart disease
  • Low-density lipoprotein

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease'. Together they form a unique fingerprint.

Cite this